VIM and lung cancer: In a preclinical study employing a Cre-dependent LSL-KrasG12D/Lkb1fl/fl lung cancer model, vimentin was expressed in CAFs surrounding collective invasion packs of epithelial tumour cells, and whole-body vimentin knockout led to a reduction of invasion packs [100].